Satellos Bioscience Inc (MSLE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 5,677 | 3,700 | 4,893 | 6,128 | 4,485 |
| Operating Income | -5,677 | -3,700 | -4,893 | -6,128 | -4,485 |
| Interest Expense | 0 | 0 | 0 | 0 | 89 |
| Other Income | 1,221 | -2,924 | 469 | 998 | -240 |
| Pre-tax Income | -4,456 | -6,624 | -4,424 | -5,130 | -4,815 |
| Net Income Continuous | -4,456 | -6,624 | -4,424 | -5,130 | -4,815 |
| Net Income | $-4,456 | $-6,624 | $-4,424 | $-5,130 | $-4,815 |
| EPS Basic Total Ops | -0.36 | -0.72 | -0.48 | -0.60 | -0.49 |
| EPS Basic Continuous Ops | -0.44 | -0.70 | -0.47 | -0.55 | -0.53 |
| EPS Diluted Total Ops | -0.36 | -0.72 | -0.48 | -0.60 | -0.49 |
| EPS Diluted Continuous Ops | -0.44 | -0.70 | -0.47 | -0.55 | -0.53 |
| EPS Diluted Before Non-Recurring Items | -0.12 | -0.72 | -0.48 | N/A | N/A |
| EBITDA(a) | $-5,668 | $-793 | $-4,891 | $-6,126 | $-4,484 |